# 2026-09199: Old Drug Gets Green Light for Generic Copycats

2026-09199, Determination That Leucovorin Calcium, Oral Solution, Equivalent to 60 Milligrams Base/Vial, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness, is a Federal Register notice from Health and Human Services Department, Food and Drug Administration published 2026-05-08, effective 2026-05-08; PRIA reads it as touching household money (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2026-09199
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-09199
- Title: Determination That Leucovorin Calcium, Oral Solution, Equivalent to 60 Milligrams Base/Vial, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
- Type: Notice
- Agencies: Health and Human Services Department; Food and Drug Administration
- Citation: 91 FR 25361
- Published: 2026-05-08
- Effective: 2026-05-08
- Comments close: not stated
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

Old Drug Gets Green Light for Generic Copycats

## Summary

The FDA has decided that leucovorin calcium oral solution (60 mg per vial) wasn’t taken off the market because it was unsafe or ineffective. This means generic drug makers can now apply to sell their versions, speeding up access for patients. No extra safety worries or delays—just more options coming soon!

## Abstract

The Food and Drug Administration (FDA or Agency) has determined that leucovorin calcium, oral solution, equivalent to (EQ) 60 milligrams (mg) base/vial, was not withdrawn from sale for reasons of safety or effectiveness. This determination will allow FDA to approve abbreviated new drug applications (ANDAs) for leucovorin calcium, oral solution, EQ 60 mg, if all other legal and regulatory requirements are met.

## Effects PRIA read

- Generic Access for Leucovorin 60 mg: benefit, medium. The FDA determined that leucovorin calcium oral solution equivalent to 60 milligrams base per vial was not withdrawn from sale for reasons of safety or effectiveness. Because of this, abbreviated new drug applications (ANDAs) that refer to this listed drug may be approved if they meet all other leg…

## Related documents

- [2026-20848](https://policyrisk.com/federal-register/2026-20848): Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods, 2026-10-13
- [2026-16296](https://policyrisk.com/federal-register/2026-16296): Substances Generally Recognized as Safe, 2026-08-11
- [2026-14073](https://policyrisk.com/federal-register/2026-14073): Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign E…, 2026-07-13
- [2026-13047](https://policyrisk.com/federal-register/2026-13047): Establishment Registration and Product Listing for Tobacco Products, 2026-06-29
- [2025-04978](https://policyrisk.com/federal-register/2025-04978): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-03-25
- [2025-01840](https://policyrisk.com/federal-register/2025-01840): Nonprescription Drug Product With an Additional Condition for Nonprescription Use, 2025-01-27

## Sources
- [2026-09199 on federalregister.gov](https://www.federalregister.gov/documents/2026/05/08/2026-09199/determination-that-leucovorin-calcium-oral-solution-equivalent-to-60-milligrams-basevial-was-not)
- [2026-09199 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-05-08/pdf/2026-09199.pdf)

## Related
- [Previous: 2026-09198, Agency Information Collection Activities; Submission to the Office of Managemen…](https://policyrisk.com/federal-register/2026-09198)
- [Next: 2026-09200, Agency Information Collection Activities; Submission to the Office of Managemen…](https://policyrisk.com/federal-register/2026-09200)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-09199 (as of 2026-06-08).
